Early Versus Late Bronchoscopy in Bone Marrow Transplantation (BMT) Patients
Completed · Not applicable
Conditions studied: Bone Marrow Transplantation
In brief
This study will evaluate the outcomes of bronchoscopy in Bome Marrow Transplant (BMT) patients who develop lung infiltrates suspicious for infections of the lungs. It will consist of two groups, one group will receive bronchoscopy within thirty six hours of enrollment, while the other group will receive bronchoscopy five days after enrollment. The purpose of this study is to determine the ideal time for bronchoscopy in this group of patients.
Key facts
- Study ID
- NCT00846352
- Run by
- Wake Forest University Health Sciences
- People needed
- 22
- Starts
- 2009-01-01
- Expected to finish
- 2010-08-02
- Last updated by the study team
- 2017-04-20
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients who have had allogenic or autologous HSCT who are admitted to the BMT, and felt to need bronchoscopy by their physician.
You may not qualify if…
- Active hemoptysis, allergies to topical and IV anesthetics with no appropriate substitutes available. Being on non-invasive positive pressure ventilation that would not allow for safe bronchoscopy.
Where it is running
- The University of Mississippi Medical Center — Jackson, Mississippi, United States
- Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States
- The Ohio State University Medical Center — Columbus, Ohio, United States
- The University of Mississippi Medical Center — Jackson, Mississippi, United States
- Wake Forest University Baptist Medical Center — Winston-Salem, North Carolina, United States
- The Ohio State University Medical Center — Columbus, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.